AB-403021

N/A

Report date: 2022/11/15 12:33:58
NME

Base Information

Drug NameAB-403021
Drug Alias NameAB-403021AB-4030-21/YBYSAB-4030-21
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVirus DiseasesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlphabeta Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAlphabeta Pharma
Inactive CompaniesN/A
Active IndicationsVirus DiseasesBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A